注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Bicycle Therapeutics PLC是一家總部位於英國的臨床階段生物製藥公司。該公司正在開發一類藥物,它稱之為Bicycles,用於治療現有療法治療不足的疾病。Bicycles是將通常與生物製劑相關的藥理學與小分子的製造和藥代動力學特性相結合的治療方式。其候選產品 BT5528、BT8009和BT1718均為Bicycles毒素偶聯物(BTC)。BT5528是第二代BTC,旨在靶向肝配蛋白A型受體2(EphA2)。BT8009是第二代BTC,旨在靶向Nectin-4,一種經過驗證的腫瘤抗原。正在開發BT1718以靶向表達1型膜基質金屬蛋白酶(MT1 MMP)的腫瘤。其候選產品BT7480和BT7455均為Bicycle腫瘤靶向免疫細胞激動劑。除了全資擁有的腫瘤產品組合外,公司還專注於其他治療領域。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Charles Swanton | 50 | 2020 | Member of Scientific Advisory Board |
Jane Grogan | 55 | 2020 | Member of Scientific Advisory Board |
Geoffrey I. Shapiro | - | 2018 | Member of Scientific Advisory Board |
Garret A. FitzGerald | - | 2020 | Member of Scientific Advisory Board |
Pierre Legault | 62 | 2019 | Non-Executive Chairman |
Caetano Reis e Sousa | - | 2020 | Member of Scientific Advisory Board |
Keith Peters | 84 | 2018 | Chairman of Scientific Advisory Board |
Kevin Lee | 54 | 2015 | CEO & Executive Director |
Janice T. Bourque | 66 | 2019 | Independent Non-Executive Director |
Richard N. Kender | 67 | 2019 | Independent Non-Executive Director |
Gregory Paul Winter | 73 | - | Co-Founder & Non-Executive Director |
Jose-Carlos Gutierrez-Ramos | 62 | 2021 | Independent Non-Executive Director |
Stephen Sands | 67 | 2024 | Independent Director |
Felix James Baker | 55 | 2024 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核